Inotuzumab
Product Specifications
CAS Number
1660159-36-3
Target
ADC Antibody, Immunology/Inflammation related, Apoptosis
Related Pathways
Antibody-drug Conjugate/ADC Related, Immunology/Inflammation, Apoptosis
Purity
>95%
Bioactivity
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. This naked antibody can be used to synthesize antibody-active molecule conjugators [Inotuzumab ozogamicin] and to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
